Bio-Rad set to acquire Stilla Technologies
Bio-Rad has entered a binding offer to purchase all equity interests in French biotech Stilla Technologies. According to ...
AstraZeneca's Imfinzi Perioperative Regimen Shows Improved Survival Outcomes In Bladder Cancer Patients
AstraZeneca's Imfinzi perioperative regimen improved survival outcomes in muscle-invasive bladder cancer, with FDA Priority ...
AstraZeneca: IMFINZI improved event-free survival, OS across MIBC
Results from a post-hoc exploratory subgroup analysis from the NIAGARA Phase III trial showed AstraZeneca’s (AZN) IMFINZI, administered ...
K’taka Cong govt hands over Covid 'scam' probe to CID
The Congress-led government in Karnataka, headed by Siddaramaiah, handed over the Covid 'scam' investigation to the Criminal ...
Understanding HMPV and easing respiratory struggles
Human Metapneumovirus (HMPV) causes respiratory infections, mainly affecting young children and the elderly. It is spread ...
eLife23h
Afadin-deficient retinas exhibit severe neuronal lamination defects but preserve visual functions
However, the study provides limited new insights into the relationship between retinal lamination defects and overall retinal function. Neural lamination is a common feature of the central nervous ...
Shab-e-Barat: Delhi Police issues traffic advisory traffic - Check restrictions, diversions
The Delhi Police mentioned that the traffic advisory for Shab-e-Barat will come into effect from 5 pm on Thursday in central ...
Earnings call transcript: Applied DNA Sciences Q1 FY25 revenue grows
Applied DNA Sciences Inc (NASDAQ:APDN) reported its financial results for the first quarter of fiscal year 2025, showcasing a notable increase in revenue but also highlighting ongoing challenges with ...